New Hot Topic: Anti-CGRP therapy in Japan – progress and expectations
CGRP-based therapy is not expected to be approved in Japan until 2021, but clinical trial data have been reported on three agents and there is a high level of expectation amongst Japanese clinicians – as Mamoru Shibata, Associate Professor in the Department of Neurology at Keio University School of Medicine, Tokyo, explains. Read more here »
|